Fulranumab

Fulranumab
Monoclonal antibody
Type Whole antibody
Source Human
Target NGF
Identifiers
CAS Number 902141-80-4 N
ATC code None
ChemSpider none
UNII 0E986JU40I YesY
Chemical data
Formula C6446H9930N1718O2018S50
Molar mass 145.39 kg/mol
 NYesY (what is this?)  (verify)

Fulranumab is a human monoclonal antibody designed for the treatment of pain.[1]

Fulranumab was developed by Johnson & Johnson.

References

  1. "Statement On A Nonproprietary Name Adopted By The USAN Council: Fulranumab" (PDF). American Medical Association.


This article is issued from Wikipedia - version of the Sunday, February 28, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.